Prognostic significance of platelet and microvessel counts in operable non-small cell lung cancer
- 1 September 2000
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 29 (3) , 169-177
- https://doi.org/10.1016/s0169-5002(00)00124-0
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Tumor Angiogenesis as a Prognostic Marker in Operable Non–Small Cell Lung CancerThe Annals of Thoracic Surgery, 1998
- Relationship between vascularity, age and survival in non-small-cell lung cancerBritish Journal of Cancer, 1997
- Immunocytochemical markers in stage I lung cancer: relevance to prognosis.Journal of Clinical Oncology, 1997
- Angiogenesis as a Prognostic Indicator of Survival in Non-Small-Cell Lung Carcinoma: a Prospective StudyJNCI Journal of the National Cancer Institute, 1997
- Revisions in the International System for Staging Lung CancerChest, 1997
- Prognostic significance of thrombocytosis in patients with primary lung cancerEuropean Respiratory Journal, 1996
- PROGNOSTIC VALUE OF ANGIOGENESIS IN OPERABLE NON-SMALL CELL LUNG CANCERThe Journal of Pathology, 1996
- Microvessel count predicts metastatic disease and survival in non‐small cell lung cancerThe Journal of Pathology, 1995
- Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party.Journal of Clinical Oncology, 1995
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990